LGC invests in new GMP analytical capability

News (ZH) - The new labs comprise additional bioanalysis and synthetic chemistry labs as well as a new GMP CMC analytical capability for batch release testing of oligonucleotide-based drug substances

LGC expands Fordham site to bolster Bioanalytical and CMC capacity

News (ZH) - LGC is expanding its Bioanalytical and CMC analytical services capacity at its site in Fordham, Cambridgeshire.

LGC updates most comprehensive catalogue of pharmaceutical reference substances

News (ZH) - The 2015 edition now includes over 3,500 impurity and drug substance reference standards as well as a selected range of primary reference standards produced under ISO Guide 34

LGC launches new service for stability testing

News (ZH) - This new service enables continuous recording and monitoring of essential data on the impact of environmental factors, such as temperature and humidity, on the quality of a pharmaceutical product

LGC launches cGMP cell-based assay capability

News (ZH) - The cGMP service is an extension to the existing cell-based assay capability that LGC’s experienced team offer for biopharmaceutical development

LGC launches new Health Sciences business

News (ZH) - LGC and HFL combine to offer first in-house testing facility for both banned substances and additives testing

LGC and reinnervate collaborate to improve in vitro toxicity testing for drug discovery

News (ZH) - LGC Standards launches reinnervate’s 3D cell culture scaffold, alvetex®

Fighting the counterfeit drug war – LGC detects fake packaging using mass spectrometry

News (ZH) - LGC announces new advance in the battle to detect counterfeit drug packaging